BACKGROUND: Thrombomodulin (TM), a glycoprotein expressed on the surfa
ce of endothelial cells, transforms protein C into a potent anticoagul
ant by binding thrombin. TM may be an important regulator of intraglom
erular coagulation because functional TM activity was demonstrated in
glomeruli isolated from normal human and rat kidneys. The role of TM i
n glomerulonephritis is unknown. EXPERIMENTAL DESIGN: Sections from 4
normal human kidneys and from kidneys of 100 patients with various for
ms of glomerulonephritis were studied by light and transmission electr
on microscopy, and by light and electron immunohistochemical technique
s using polyclonal antibodies to recombinant human TM, and monoclonal
antibodies to the membrane attack complex of the complement system. Th
e expression of TM was graded from 0 to 4 according to the intensity a
nd extent of the distribution, and the results were compared with the
clinicopathologic findings. RESULTS: In normal glomeruli and in glomer
uli with minimal abnormalities, a small amount of TM was localized at
the vascular pole only (grade 0-1). In membranoproliferative glomerulo
nephritis and lupus glomerulonephritis, the amount of TM found on the
plasma membrane of endothelial cells was significantly increased (grad
es 2 to 4). The expression of TM was directly correlated with proteinu
ria (p < 0.001), glomerular hypercellularity (p < 0.01), and number of
subendothelial immune deposits (p < 0.01). In contrast, in other form
s of glomerular diseases, TM was not increased and no correlation was
found with the clinicopathologic parameters. CONCLUSIONS: In membranop
roliferative glomerulonephritis and lupus glomerulonephritis, the amou
nt of TM expressed by the plasma membranes of glomerular endothelial c
ells is increased, and this finding is a marker of disease activity. T
he significance of an increased expression of an endothelial anticoagu
lant glycoprotein in diseases characterized by pathologic intraglomeru
lar coagulation is unknown, and requires further studies.